Last reviewed · How we verify
NCT05360511
Erythropoietin Gel as an Adjunct to Xenograft in the Surgical Management of Intrabony Periodontal Defects
EARLY_PHASE1 trial testing particulate xenograft + erythropoietin gel. in Periodontal Bone Loss in 26 participants. Completed in 1 October 2023.
1 September 2023
Quick facts
| Lead sponsor | Ain Shams University |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 26 |
| Start date | 1 July 2022 |
| Primary completion | 1 September 2023 |
| Estimated completion | 1 October 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- particulate xenograft + erythropoietin gel. — full drug profile →
- particulate xenograft
Conditions studied
- Periodontal Bone Loss — all drugs for Periodontal Bone Loss →
Sponsor
Ain Shams University
Who can join
Adults 20 to 50, any sex, with Periodontal Bone Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate the use of erythropoietin gel as an adjunct to xenograft in the surgical management of intrabony periodontal defects.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hydrogels in the clinic: An update.
Clegg JR, Adebowale K, Zhao Z, Mitragotri S. · · 2024 · cited 64× · PMID 39545079 · DOI 10.1002/btm2.10680
Verify or expand the search:
- PubMed search for NCT05360511
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Periodontal Bone Loss
Currently open trials in the same condition.
- NCT07146776 — Treatment of Intrabony Defects With Injectable Platelet-Rich Fibrin and Xenogenic Grafts · NA · recruiting
- NCT06744348 — Entire Papilla Preservation Technique in the Treatment of Periodontal IntraBony Defects: a 1-year Follow-up Study · active not recruiting
- NCT05533528 — Periodontal Granulation Tissue Preservation in Surgical Periodontitis Treatment · NA · recruiting
- NCT03997578 — Non-incised Papillae Surgical Approach (NIPSA) and Connective Tissue Graft Plus Emdogain for Periodontal Defects · NA · recruiting
Other Ain Shams University trials
Trials by the same sponsor.
- NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
- NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
- NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
- NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05360511 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
- Last refreshed: 16 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05360511.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing